Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Elliott

Showing results (121-130 of 215) with videos related to

Pageof 22
Sort By:
Future Cardiology|September 23, 2017
Severe hypertrophic cardiomyopathy in a patient with atypical Anderson-Fabry diseaseDaniele Masarone, Giovanni Duro, Santo Dellegrottaglie, et al.
Heart Rhythm|May 28, 2025
Effect of leadless left ventricular endocardial and left bundle area pacing on biventricular repolarization metricsNadeev Wijesuriya, Marina Strocchi, Mark Elliott, et al.
Pharmacology Research & Perspectives|December 7, 2018
A comparison of biological activity of commercially available purified native botulinum neurotoxin serotypes A1 to F1 in vitro, ex vivo, and in vivoSarah Donald, Mark Elliott, Bryony Gray, et al.
Journal of Cardiovascular Echography|June 19, 2018
Diagnostic Clues for the Diagnosis of Nonsarcomeric Hypertrophic Cardiomyopathy (Phenocopies): Amyloidosis, Fabry Disease, and Mitochondrial DiseaseGiuseppe Limongelli, Daniele Masarone, Marina Verrengia, et al.
The American Journal of Psychiatry|October 4, 2005
Levels-of-processing effect on frontotemporal function in schizophrenia during word encoding and recognitionJ Daniel Ragland, Ruben C Gur, Jeffrey N Valdez, et al.
Circulation. Genomic and Precision Medicine|December 4, 2023
Impact of <i>GLA</i> Variant Classification on the Estimated Prevalence of Fabry Disease: A Systematic Review and Meta-Analysis of Screening StudiesEmanuele Monda, Gaetano Diana, Francesca Graziani, et al.
Kidney International Reports|May 20, 2024
Implications of Implementing the 2021 CKD-EPI Equation Without Race on Managing Patients With Kidney Disease in British Columbia, CanadaMohammad Atiquzzaman, Lee Er, Ognjenka Djurdjev, et al.
Heart Rhythm O2|June 11, 2021
Noninvasive electrocardiographic assessment of ventricular activation and remodeling response to cardiac resynchronization therapyThomas Jackson, Simon Claridge, Jonathan Behar, et al.
American Journal of Respiratory and Critical Care Medicine|June 17, 2008
Decline in NRF2-regulated antioxidants in chronic obstructive pulmonary disease lungs due to loss of its positive regulator, DJ-1Deepti Malhotra, Rajesh Thimmulappa, Ana Navas-Acien, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 24, 2016
Lisdexamfetamine Effects on Executive Activation and Neurochemistry in Menopausal Women with Executive Function DifficultiesSheila Shanmugan, James Loughead, Ravi Prakash Reddy Nanga, et al.
Pageof 22

Showing results (121-130 of 215) with videos related to

Sort By:
Pageof 22
Future Cardiology|September 23, 2017
Severe hypertrophic cardiomyopathy in a patient with atypical Anderson-Fabry diseaseDaniele Masarone, Giovanni Duro, Santo Dellegrottaglie, et al.
Heart Rhythm|May 28, 2025
Effect of leadless left ventricular endocardial and left bundle area pacing on biventricular repolarization metricsNadeev Wijesuriya, Marina Strocchi, Mark Elliott, et al.
Pharmacology Research & Perspectives|December 7, 2018
A comparison of biological activity of commercially available purified native botulinum neurotoxin serotypes A1 to F1 in vitro, ex vivo, and in vivoSarah Donald, Mark Elliott, Bryony Gray, et al.
Journal of Cardiovascular Echography|June 19, 2018
Diagnostic Clues for the Diagnosis of Nonsarcomeric Hypertrophic Cardiomyopathy (Phenocopies): Amyloidosis, Fabry Disease, and Mitochondrial DiseaseGiuseppe Limongelli, Daniele Masarone, Marina Verrengia, et al.
The American Journal of Psychiatry|October 4, 2005
Levels-of-processing effect on frontotemporal function in schizophrenia during word encoding and recognitionJ Daniel Ragland, Ruben C Gur, Jeffrey N Valdez, et al.
Circulation. Genomic and Precision Medicine|December 4, 2023
Impact of <i>GLA</i> Variant Classification on the Estimated Prevalence of Fabry Disease: A Systematic Review and Meta-Analysis of Screening StudiesEmanuele Monda, Gaetano Diana, Francesca Graziani, et al.
Kidney International Reports|May 20, 2024
Implications of Implementing the 2021 CKD-EPI Equation Without Race on Managing Patients With Kidney Disease in British Columbia, CanadaMohammad Atiquzzaman, Lee Er, Ognjenka Djurdjev, et al.
Heart Rhythm O2|June 11, 2021
Noninvasive electrocardiographic assessment of ventricular activation and remodeling response to cardiac resynchronization therapyThomas Jackson, Simon Claridge, Jonathan Behar, et al.
American Journal of Respiratory and Critical Care Medicine|June 17, 2008
Decline in NRF2-regulated antioxidants in chronic obstructive pulmonary disease lungs due to loss of its positive regulator, DJ-1Deepti Malhotra, Rajesh Thimmulappa, Ana Navas-Acien, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 24, 2016
Lisdexamfetamine Effects on Executive Activation and Neurochemistry in Menopausal Women with Executive Function DifficultiesSheila Shanmugan, James Loughead, Ravi Prakash Reddy Nanga, et al.
Pageof 22